-
Open-label Extension Study of Long-term Safety and Tolerability of Foslevodopa/Foscarbidopa for Treatment of Advanced Parkinson’s Disease
-
Operationalising goal setting as an outcome measure: Experience from the PRIME-UK randomised controlled trial
-
Opicapone versus entacapone: Head-to-head comparison of Healthcare Resource Utilisation in COMT-I naïve People with Parkinson’s
-
Opicapone’s Effects on Progression Scales in Relation to the 9-Symptom Wearing-off Questionnaire: the OPTIPARK Study
-
Opsoclonus Myoclonus Syndrome due to subdural hematoma: an uncommon etiology
-
Optimal topographic characteristics of focused ultrasound unilateral thalamotomy for tremor-dominant Parkinson´s disease
-
Optimizing DBS in PD: Investigating LFP beta power fluctuations in response to chronic stimulation
-
Orthostatic hypotension and frailty
-
Orthostatic hypotension exacerbates gray matter atrophy related to REM sleep behavior disorder in de novo Parkinson’s disease
-
Orthostatic vital sign changes do not influence 5-year motor outcomes in PD
- « Previous Page
- 1
- …
- 121
- 122
- 123
- 124
- 125
- …
- 186
- Next Page »